Brown Capital Management, an investment management company, released its fourth quarter 2025 investor letter for “The Brown Capital Management Small Company Fund”. A copy of the letter can be ...

New Delhi [India], December 31 (ANI): In a landmark achievement for Indian medicine, the Ophthalmology Department at Army Hospital (Research & Referral), Delhi Cantt, has successfully performed ...

NEW DELHI: A leading Army hospital here has successfully conducted a "pioneering procedure" using a state-of-the-art 3D operating microscope, combining advanced imaging with minimally invasive ...

Glaukos has claimed a series of regulatory clearances in Europe for its micro-scale surgical implants to treat patients with glaucoma, expanding the company’s reach overseas. The green lights under ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal ...

iDose TR, at left, is much smaller than a typical eye drop Shares of Aliso Viejo-based Glaukos Corp. soared 25% on Dec. 14 to a market cap approaching $4 billion (NYSE: GKOS), after the maker of ...

A physician at N.C.-based Wilmington Eye performed the first successful implant of the iStent Infinite at Wilmington Eye Surgery Center. This marks the first time a glaucoma device has been implanted ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...

Novel Three-Stent Injectable System Designed to Provide Foundational, 24/7 IOP Control ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and ...

NEW ORLEANS -- Patients with glaucoma who were treated with a microstent during cataract surgery retained benefits over traditional surgery at 5 years, a randomized study found. In addition, rate of ...